New chief at BioDelivery Sciences

BioDelivery Sciences International, a specialty pharmaceutical company with a focus in pain management and addiction medicine, announced that Herm Cukier has been appointed Chief Executive Officer and a member of the Board of Directors of BioDelivery Sciences effective May 8, 2018.  Former President and Chief Executive Officer, Dr. Mark A. Sirgo, will continue his role as Vice Chairman of the Board of Directors and, along with current President Scott Plesha, will work closely with Mr. Cukier in the transition of responsibilities. 

"Our Board of Directors is very pleased to announce Herm’s appointment as CEO and member of our Board," said Dr. Frank O’Donnell, Chairman of the Board of BDSI.  "Herm brings to BDSI a wealth of commercial experience and a consistent track record of successfully leading and transforming businesses.  Herm has successfully applied his vast commercial experience over multiple commercial organizations that involved over 50 brands.  As such, we believe he is well equipped to make immediate contributions to BDSI and support the future growth of BELBUCA and BUNAVAIL.  Our Board looks forward to working with Herm and is confident, given Herm’s background and experience, that he is the right person to lead BDSI to the next level."

Register as Visitor to CPhI China 2018!